Sandrine Dury arrives at N-SIDE this November to take the lead of its Life Sciences Business Unit Louvain-la-Neuve, November 23 - N-SIDE, a leading provider of...
Read moreLighthouse will double the amount of active clinical trials managed by N-SIDE to 1,400 within 3 years
Read moreOn average, between 55-75% of drugs are wasted in clinical trials. Overproduction has historically been accepted in clinical supply and manufacturing processes...
Read moreClinical trial supply managers work hard to ensure trial protocols, supply plans, and resupply strategies are designed for maximum efficiency.
Read moreAn average of 95% of clinical supply managers face some level of supply risk during their trials. Moreover, supply chain bottlenecks can generate 2 to 4 months...
Read moreAfter a couple of quieter summer months, N-SIDE is headed to conferences again! Missed us last year or want to meet with us again? You're in luck! Find out which...
Read moreDesigning the packaging and labeling for investigational new drugs (INDs) and investigational medicinal products (IMPs) can be a complex task — especially when...
Read moreDrug supply chain management is a balancing act. You need to ensure enough drug is available to meet patient demand and that supply is allocated where it’s most...
Read moreAre you making the best possible decisions about your clinical trial manufacturing?
Read more